• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROGAV 2.0 WITH SHUNTASSISTANT 2.0 10; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROGAV 2.0 WITH SHUNTASSISTANT 2.0 10; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX640T
Medical Device Problem Code Mechanical Problem (1384)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 12/29/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Visual inspection: during the investigation, no significant deformations or damage of the valve were determined but signs of the adjustment tool on the plastic bag could be determined.Permeability test: not applicable, due to the sterile packaging computer controlled test: not applicable, due to the sterile packaging adjustment test: the progav 2.0 was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function operates as expected but the braking force measurement is not applicable, due to the sterile packaging.Internal inspection: the internal inspection ist noch necessary results: based on our investigation results, we cannot determine functional deviations or other abnormalities in the product.How the abovementioned functional impairment occurred is not clear to us at the time of examination.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Event or Problem Description
It was reported that a progav 2.0 shunt system (#fx640t) was not adjustable preoperatively in the sterile packaging.The complainant's device was returned to the manufacturer for evaluation.No patient was involved.
 
Additional Manufacturer Narrative
Correction: b1 + e1 + h1.
 
Event or Problem Description
It was reported that a progav 2.0 shunt system (#fx640t) was not adjustable preoperatively in the sterile packaging.The complainant's device was returned to the manufacturer for evaluation.No patient was involved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 WITH SHUNTASSISTANT 2.0 10
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key18574543
Report Number3004721439-2023-00402
Device Sequence Number20796593
Product Code JXG
UDI-Device Identifier04041906501983
UDI-Public4041906501983
Combination Product (Y/N)N
Initial Reporter StateAR
Initial Reporter CountryUS
PMA/510(K) Number
K190174
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberFX640T
Device Catalogue NumberFX640T
Device Lot Number20071018
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/11/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/29/2023
Supplement Date Received by Manufacturer01/29/2024
Initial Report FDA Received Date01/24/2024
Supplement Report FDA Received Date01/29/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/23/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-